ATE520711T1 - Knochenmorphogenetisches protein 4 und osteogene vorrichtungen und pharmazeutische produkte, die dieses enthalten - Google Patents

Knochenmorphogenetisches protein 4 und osteogene vorrichtungen und pharmazeutische produkte, die dieses enthalten

Info

Publication number
ATE520711T1
ATE520711T1 AT06743555T AT06743555T ATE520711T1 AT E520711 T1 ATE520711 T1 AT E520711T1 AT 06743555 T AT06743555 T AT 06743555T AT 06743555 T AT06743555 T AT 06743555T AT E520711 T1 ATE520711 T1 AT E520711T1
Authority
AT
Austria
Prior art keywords
morphogenetic protein
bone morphogenetic
same
products containing
pharmaceutical products
Prior art date
Application number
AT06743555T
Other languages
English (en)
Inventor
Elli Birr
Mari Ulmanen
Oili Hietala
Marja Juustila
Heli Korkala
Pekka Jalovaara
Original Assignee
Bbs Bioactive Bone Substitutes Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FI20055257A external-priority patent/FI121070B/fi
Priority claimed from FI20055258A external-priority patent/FI119373B/fi
Application filed by Bbs Bioactive Bone Substitutes Oy filed Critical Bbs Bioactive Bone Substitutes Oy
Application granted granted Critical
Publication of ATE520711T1 publication Critical patent/ATE520711T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/51Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT06743555T 2005-05-27 2006-05-26 Knochenmorphogenetisches protein 4 und osteogene vorrichtungen und pharmazeutische produkte, die dieses enthalten ATE520711T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI20055257A FI121070B (fi) 2005-05-27 2005-05-27 Luun morfogeneettinen proteiini 6, sitä koodaava DNA, nukleotidivektori, rekombinantti isäntäsolu, farmaseuttinen koostumus ja osteogeeninen väline
FI20055258A FI119373B (fi) 2005-05-27 2005-05-27 Luun proteiineja
PCT/FI2006/050213 WO2006125867A1 (en) 2005-05-27 2006-05-26 Bone morphogenetic protein 4 and osteogenic devices and pharmaceutical products containing thereof

Publications (1)

Publication Number Publication Date
ATE520711T1 true ATE520711T1 (de) 2011-09-15

Family

ID=37451666

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06743555T ATE520711T1 (de) 2005-05-27 2006-05-26 Knochenmorphogenetisches protein 4 und osteogene vorrichtungen und pharmazeutische produkte, die dieses enthalten

Country Status (4)

Country Link
US (1) US7807627B2 (de)
EP (1) EP1885750B1 (de)
AT (1) ATE520711T1 (de)
WO (1) WO2006125867A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1578348A4 (de) * 2002-02-08 2011-03-16 Wyeth Llc Formulierung mit bioaktiven mitteln und verwendungsverfahren dafür
US11078248B2 (en) 2010-03-19 2021-08-03 Lifenet Health BMP peptides and methods of use
CA2794165A1 (en) * 2010-03-24 2011-09-29 Lifenet Health Bmp-4 peptides & methods of use
KR101348284B1 (ko) * 2010-09-09 2014-01-03 주식회사 나이벡 인간 유래 세포 투과성 펩타이드와 생리활성 펩타이드 결합체 및 그 용도

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6150328A (en) 1986-07-01 2000-11-21 Genetics Institute, Inc. BMP products
US5266683A (en) * 1988-04-08 1993-11-30 Stryker Corporation Osteogenic proteins
US5399677A (en) 1993-12-07 1995-03-21 Genetics Institute, Inc. Mutants of bone morphogenetic proteins
US6083690A (en) 1995-06-02 2000-07-04 Osteoscreen, Inc. Methods and compositions for identifying osteogenic agents
US20030032586A1 (en) 1997-05-15 2003-02-13 David C. Rueger Compositions for morphogen-induced osteogenesis
US6677432B1 (en) * 1998-10-07 2004-01-13 Stryker Corporation Mutations of the C-terminal portion of TGF-β superfamily proteins
PT1131087E (pt) 1998-11-13 2004-12-31 Curis Inc Metodos de alivio de sintomas de cancro

Also Published As

Publication number Publication date
US7807627B2 (en) 2010-10-05
WO2006125867A1 (en) 2006-11-30
EP1885750A1 (de) 2008-02-13
EP1885750A4 (de) 2009-04-01
US20090214653A1 (en) 2009-08-27
EP1885750B1 (de) 2011-08-17

Similar Documents

Publication Publication Date Title
DE60224291D1 (de) System zur antikörperexpression und- synthese
AU2002305450A1 (en) Proteomimetic compounds and methods
JO2534B1 (en) Pyrimidines carrying alternatives of sulfoximine as CDK and / or VEGF inhibitors and their production and use as pharmaceutical agents
AU2003263552A1 (en) Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules
ATE446313T1 (de) Muteine von tränen-lipocalin
SE0301010D0 (sv) Novel compounds
SE0301009D0 (sv) Novel compounds
DE60327999D1 (de) Azolylaminoazine als inhibitoren von proteinkinasen
CY1111070T1 (el) Παραγωγα 2-αμινο-κουιναζολινης χρησιμα ως αναστολεις της β-σεκρετασης (bace)
EP2213684A3 (de) Nogo-A-Antikörper für die Behandlung von Alzheimer-Krankheit
WO2005038012A3 (en) Cartilage and bone repair and regeneration using postpartum-derived cells
EP1673078A4 (de) Benzylether- und benzylamino-beta-sekretase-hemmer zur behandlung von alzheimer-krankheit
CY1111086T1 (el) Παραγωγα 2-αμινο-κιναζολινης χρησιμα ως αναστολεις της βητα-σεκρετασης (bace)
ATE256740T1 (de) Menschliches sdf-5 protein und diesbezügliche zusammensetzungen
DE60313004D1 (de) Alpha-7-nikotinsäure-rezeptoragonisten und statine in kombination
EP1423414A4 (de) Neue depsipeptide und verfahren zu deren herstellung
WO2004093804A3 (en) Human polypeptides encoded by polynucleotides and methods of their use
MA27880A1 (fr) Derives de tetrahydrocarbazole et leur utilisation pharmaceutique
ATE549353T1 (de) Aktive varianten des il-18 bindenden proteins und dessen medizinische verwendungen
WO2008100618A3 (en) Carbon-linked tetrahydro-pyrazolo-pyridine modulators of cathepsin s
ATE340257T1 (de) Histonedeacetylase 9
WO2004094651A3 (en) Novel human polypeptides encoded by polynucleotides
ATE520711T1 (de) Knochenmorphogenetisches protein 4 und osteogene vorrichtungen und pharmazeutische produkte, die dieses enthalten
ATE533781T1 (de) Heparin-bindungsstelle enthaltendes knochenmorphogenetisches protein 6 und osteogene vorrichtungen und pharmazeutische produkte, die diese enthalten
ATE543833T1 (de) Bmp-7-varianten-zusammensetzungen, verfahren und verwendungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties